Pharmaceutical Executive January 5, 2024
The LillyDirect platform will allow patients who are prescribed the popular weight loss drug Zepbound to obtain the drug via Lilly’s at-home prescription delivery service.
Eli Lilly has announced a new digital platform that will sell certain drugs directly to consumers with a prescription for conditions such as diabetes, obesity, and migraine. LillyDirect will facilitate access to medications by connecting patients with independent telehealth providers and other disease management resources, bypassing the need to obtain a prescription from a physician and then going to a pharmacy to fill it.1
“A complex US healthcare system adds to the burdens patients face when managing a chronic disease. With LillyDirect, our goal is to relieve some of those burdens by simplifying the patient...
Today's Sponsors
Today's Sponsor